Newbury Pharmaceuticals AB (publ) reported earnings results for the full year ended August 31, 2023. For the full year, the company reported sales was SEK 10.27 million compared to SEK 5.52 million a year ago. Net loss was SEK 19.43 million compared to SEK 14.67 million a year ago.